GABAergic System in the Anxiolytic Effect of Proproten: Experimental Study

Bulletin of Experimental Biology and Medicine

Volumn 135-136, Issue SUPPL. 1, 2003, Pages 125-127

  Voronina, T A ^a   Molodavkin, G M ^a   Sergeeva, S A ^a   Epstein, O I ^a  

^a Materia Medica Holding R   (Russian Federation)

Author keywords

Antibodies to S100 protein; Anxiolytic; Diazepam; GABAergic transmission; Mexidol; Proproten; S100 protein; Tranquilizer; Ultralow doses

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; BICUCULLINE; BRAIN PROTEIN; CHLORIDE CHANNEL BLOCKING AGENT; DIAZEPAM; MEXIDOL; PICROTOXIN; PROPROTEN; PROTEIN ANTIBODY; PROTEIN S 100; TRANQUILIZER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRINKING BEHAVIOR; DRUG EFFECT; GABAERGIC SYSTEM; INCIDENCE; LOW DRUG DOSE; MALE; NEUROTRANSMISSION; NONHUMAN; OUTBREEDING; PUNISHMENT; RAT; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIBODIES; BEHAVIOR, ANIMAL; BICUCULLINE; DIAZEPAM; MALE; PICROTOXIN; RATS; RECEPTORS, GABA-A; S100 PROTEINS;

ANIMALIA;

EID: 17444440818     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024776007215     Document Type: Article

References (13)

1. Yu. A. Aleksandrovskii, Borderline Mental Disorders [in Russian], Moscow (2000).
2. T. A. Voronina and S. B. Seredenin, Manual on Experimental (Preclinical) Studies of New Pharmacological Preparations [in Russian], Moscow (2000), pp. 126-130.
3. T. A. Voronina, Psikhofarmakol. Biol. Narkol., No. 1, 2-12 (2001).
4. P. V. Sergeev, N. L. Shimanovskii, and V. I. Petrov, Receptors for Physiologically Active Substances [in Russian], Volgograd (1999).
5. M. B. Shtark, Brain-Specific Proteins (Antigens) and Functions of Neurons [in Russian], Novosibirsk (1985).
6. M. B. Shtark, N. A. Beregovoi, M. V. Starostina, et al., XIII Congress of Russian Psychiatrists, Moscow, October 2000, Abstracts of Papers, p. 374.
7. O. I. Epstein, Byull. Sib. Otd. Ros. Akad. Med. Nauk, No. 1, 132-149 (1999).
8. O. I. Epstein, N. A. Beregovoi, N. S. Sorokina, et al., Byull. Eksp. Biol. Med., 127, No. 3, 317-320 (1999).
9. O. I. Epstein, T. V. Vorob'eva, O. G. Berchenko, et al., Ibid., 127, No. 5, 547-549 (1999).
10. O. I. Epshtein, Kh. L. Gainutdinov, and M. B. Shtark, Ibid., 127, No. 4, 466-477 (1999).
11. O. I. Epstein, T. A. Voronina, G. M. Molodavkin, and S. A. Sergeeva, I International Symposium "Stress and Extreme Conditions", Kara-Dag, Feodosiya (2002), pp. 90-91.
12. C. Heizmann, G. Fritz, and B. W. Schafer, Front. Biosci., 7, 1356-1368 (2002).
13. D. Lewis and T. J. Teyler, Brain Res., 383, No. 1-2, 159-164 (1986).